We delve into the development of Lucida Medical. Led by long time tech entrepreneur, Dr Antony Rix, he explains how they have grown with purpose and how that has set them apart.

This episodes covers Antony’s transition into the world medical devices, how he and the team has continuously solved problems which has led to industry accuracy of their algorithm. And finally the purpose of Antony and Lucida’s mission which can never be underestimated.

About Dr Anthony Rix

Dr Antony Rix, CEO and Co-Founder, is a serial entrepreneur with 25 years' experience in software and AI. Antony’s first startup, Psytechnics, was based on his PhD in machine learning and was acquired by Netscout in 2011. After 12 years developing software, communications and medical devices at Cambridge technology consultancy TTP, he returned to startups in 2016 to found 8power, an industrial sensor manufacturer. He has led Lucida Medical since its inception in 2019, initially developing the company’s Pi technology and since 2021 building the team.

For People with Purpose is what SciPro stands for.

Beats Medical is a purpose-driven DTx startup based in Ireland, working on CNC and other rare diseases, making their technology part of the solution.

There is so much to love about this episode, and the crossover between SciPro and Beats Medical is clear to see. We are thankful that Ciara Clancy, the CEO, joined Nick for the penultimate episode of Series 5. In this episode, Ciara shares ideas on how to build a company driven by purpose, influencing both business decisions and hiring. As an added bonus, Ciara shares her words of wisdom when it comes to pharma partnerships.

About Ciara: Dr. Ciara Clancy, founder, and CEO, is a chartered physiotherapist and researcher who attained a PhD in Neurosurgery Outcomes. While working in the clinic as a physiotherapist, Ciara realized the exponential reach she could have in treating patients through technology. From this, Ciara founded Beats Medical to deliver automated, clinically proven therapies to people with Central Nervous System conditions and Rare Diseases through technology. As a multi-award-winning entrepreneur, Ciara has been recognized by industry titans such as Google, Cartier, and EY, among many more. Ciara’s passion for changing the future of healthcare has brought her to the forefront of prominent industry events such as WIRED Health, Google Demo Day, CNS Leaders Forum, and saw her named in the Forbes 30 Under 30 list in 2019. In 2022, Ciara was awarded the European Prize for Women Innovators.

We are joined by their CTO, Eric Greveson to hear what has changed since the first episode. It is fair to say a lot has happened for Eric, Brainomix, SciPro and Nick in the last three years.

Eric is the CTO of Brainomix. He received his 1st class M.Eng.in Engineering from Cambridge University, and has worked on a wide variety of computer vision projects. These include video processing and 3D graphics algorithms, real-time data capture software, parallel grid computing systems, and data visualization. He has extensive experience in software engineering, design, and programming with languages such as C++ and Python. At Brainomix, Eric works with the clinical and business teams to deliver the company's state-of-the-art medical imaging software. Enjoy the episode.

Very rarely do we get a chance to delve into the innovation within large multi national companies. Therefore we are very proud to present the latest episode with Darren Porras, who has spent his career innovating in large medical device companies and continues to support them and smaller start ups in his consulting role.

This is a great episode if you are looking for the culture of innovation in different size of companies and how the landscape in the industry has changed in recent years.

Enjoy the episode.

After more than 10 years as a powerhouse in DTx it was a pleasure to have Kim join us on the podcast. Kim Baden-Kristensen is the CEO and Co-Founder of Brain+. A company based in Copenhagen that are seeking to meet the challenge of Dementia and Alzheimer's care by harnessing the power of technology and AI. In this episode, we take a deep dive into his career, his purpose and what Brain+ have achieved, achieving and seeking to achieve.

Enjoy the episode.

LLMs in healthcare.

This is the episode we finally tackled the topic in depth. In this episode Nick is joined by the CTO and Co-Founder of Alex Therapeutics, Oliver Fleetwood.

Not only do they discuss the technology behind the fantastic Alex product and future products but they tackle the readiness of patients and regulatory bodies for LLMs to be used in mental health care.

This is a super exciting episode so enjoy!

Building a MedTech start-up with purpose. ..

Nick Mahoney is joined by CEO of Sonio, Cecile Dubois. Sonio is an AI-software guiding practitioners during prenatal ultrasound scans to secure prenatal screening and optimize prenatal diagnosis.

In this episode, Nick unpacks the technology behind the amazing product and how Cecile has balanced building a diverse company with industry expertise.

In the first episode of series five, host Nick Mahoney was joined by the CCO of Doccla, Tom Breeze. For the first time in our podcast studio, Nick and Tom discuss the transition he made from private equity to healthcare and what drives him about the mission of Doccla.

Situated in an exciting period of growth for Doccla, this is great episode to learn more about remote patient monitoring systems and the go to market strategies needed across different locations.

In this episode Nick and Jon discuss the future of hiring into Computational Chemistry teams and how the use of AI is affecting this. A topic Nick spoke at great length about at the #aisummit also. Jon has been through many technological changes in the industry and so his expertise and knowledge shines through with some great nuggets of information. Jon Heal is the Silico team (also known as prosaRx) leader at RxCelerate which is a rapidly growing company conducting service based work for drug discovery programs based in Cambridge, UK. Jon was previously a co-founder of Prosarix Ltd and Head of Computational Chemistry at Evolva SA, a swiss biotech company focussing on innovative approaches within synthetic biology space. Jon has over 20 years experience of drug discovery, was instrumental in the development of the ProtoDiscovery™ technology platform and its application in over 50 drug discovery projects with many different client companies.

Following the successful conclusion of another JP Morgan Conference in 2023, Nick sat down with Dr Juana Candia to hear about her take on this year's conference and what we should take from it.

Juana brings more than 20 years of leadership experience in Biotech, Precision Medicine, and Cell & Gene Therapy. She is the co-founder of one of the first Biotech startups in South America, pursued scientific discoveries and built businesses in seven countries and four continents. Accelerated innovation pipelines, authored 20+ patents families, designed, and delivered growth strategies resulting in business turnarounds and double-digit growths while working for Roche, DSM, Novartis, GSK, and Scailyte (Start-up). Currently serving on Boards of Directors and Advisers to emerging companies with transformative technologies and disruptive business models.